Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocilizumab Monotherapy and Combination in Early Rheumatoid Arthritis (FUNCTION)
NCT01007435Phase 3Completed
- Sponsor
- Roche
- Start
- Oct 2009
- Primary completion
- May 2012
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 36
01
Overview
A Phase 3 trial of tocilizumab in rheumatoid arthritis (RA), sponsored by Roche. Started Oct 2009; status: completed.
02
Drugs
tocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01007435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01007435.